PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
12.28%
Revenue growth 1.25-1.5x QCOM's 8.88%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
13.83%
Gross profit growth above 1.5x QCOM's 2.93%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
24.58%
EBIT growth above 1.5x QCOM's 12.51%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
24.89%
Operating income growth above 1.5x QCOM's 12.51%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
18.19%
Net income growth at 75-90% of QCOM's 24.05%. Bill Ackman would press for improvements to catch or surpass competitor performance.
23.46%
EPS growth similar to QCOM's 25.64%. Walter Schloss would assume both have parallel share structures and profit trends.
24.05%
Similar diluted EPS growth to QCOM's 24.36%. Walter Schloss might see standard sector or cyclical influences on both firms.
-0.22%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
0.10%
Slight or no buyback while QCOM is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
0.22%
Dividend growth under 50% of QCOM's 11.20%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
32.18%
OCF growth under 50% of QCOM's 149.66%. Michael Burry might suspect questionable revenue recognition or rising costs.
39.85%
FCF growth under 50% of QCOM's 178.43%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
46.99%
10Y revenue/share CAGR under 50% of QCOM's 252.75%. Michael Burry would suspect a lasting competitive disadvantage.
21.16%
5Y revenue/share CAGR under 50% of QCOM's 89.73%. Michael Burry would suspect a significant competitive gap or product weakness.
24.02%
3Y revenue/share CAGR above 1.5x QCOM's 13.66%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
407.30%
10Y OCF/share CAGR above 1.5x QCOM's 156.76%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
41.89%
5Y OCF/share CAGR at 50-75% of QCOM's 65.56%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
34.40%
3Y OCF/share CAGR above 1.5x QCOM's 4.01%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
107.43%
Net income/share CAGR at 50-75% of QCOM's 155.72%. Martin Whitman might question if the firm’s product or cost base lags behind.
84.05%
5Y net income/share CAGR 1.25-1.5x QCOM's 58.68%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
68.48%
3Y net income/share CAGR above 1.5x QCOM's 7.30%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
28.66%
Below 50% of QCOM's 168.48%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
6.60%
Below 50% of QCOM's 32.68%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
1.90%
Positive short-term equity growth while QCOM is negative. John Neff sees a strong advantage in near-term net worth buildup.
1149.23%
10Y dividend/share CAGR above 1.5x QCOM's 340.25%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
194.94%
5Y dividend/share CAGR 1.25-1.5x QCOM's 146.74%. Bruce Berkowitz verifies that high dividend hikes remain sustainable, not a sign of over-distribution.
35.78%
3Y dividend/share CAGR at 50-75% of QCOM's 51.81%. Martin Whitman might see a weaker short-term approach to distributing cash.
7.34%
AR growth well above QCOM's 11.57%. Michael Burry fears inflated revenue or higher default risk in the near future.
-3.62%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
3.33%
Asset growth above 1.5x QCOM's 1.45%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
3.48%
75-90% of QCOM's 4.50%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
-0.03%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
3.52%
We increase R&D while QCOM cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-2.64%
We cut SG&A while QCOM invests at 0.16%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.